Jan 21, 2020

Pilot study of counterpulsation system successful in patients with HF

A novel implantable extra-aortic counterpulsation system was safe and improved functional status and quality of life in patients with HF in a recent pilot study. Researchers evaluated the feasibility, safety and potential efficacy of the counterpulsation system (C-Pulse System, Sunshine Heart Inc.), which includes a nonobligatory, non-blood contacting counterpulsation heart assist pump designed

Proceed to the page: http://linkis.com/ia7HY

Similar Articles Added Earlier

Similar Articles Added Today

  • 10 Compelling Reasons Why You Need jitni dafa mp3 song

    Baccarat Strategies Wherever Are They From? The Reddit Baccarat recommendations are a fantastic source for specifics of the sport and might typically offer a improved Perception into exactly what is included. The foundations are very simple, but it will require a talented player to be successful...

  • The History of 김포공항 - sethijpv147.simplesite.com

    There’s a standard false impression that people who seek out no cost things online usually are not great potential clients as prospects. Whilst that may be real in lots of situations, that doesn’t signify they can’t enable you to earn a living. We’re heading to debate how you can make revenue from...

  • f0llxta804

    At a median sizing of 8mm-14mm, Tahitian cultured pearlsespecially All those specimens that happen to be gem-high quality and roundare quite expensive. According to the newest details from t...

Most Recent healio.com Articles

  • Efficacy, safety of aspirin for treatment of patients with diabetes, CAD unclear

    BOSTON — The benefits of using aspirin, alone or with a platelet inhibitor, for the treatment of patients with diabetes at high-risk for CVD are still unclear, according to presenters at the Cardiometabolic Health Congress. A debate between Ph. Gabriel Steg, MD, professor of cardiology at...

  • Apixaban superior to warfarin regardless of renal function in patients with AF

    Renal function status had no effect on the superiority of apixaban in efficacy and safety compared with warfarin in patients with atrial fibrillation, according to data published in JAMA Cardiology. In the ARISTOTLE trial, apixaban (Eliquis, Bristol-Myers Squibb/Pfizer) was associated with reduced...

  • Strict glycemic control did not affect survival after CABG

    There was no difference in survival after CABG between patients who underwent a strict glycemic control strategy compared with those who underwent a liberal strategy, according to recent study data. Researchers assessed long-term survival in patients (mean age, 62.7 years; 16% women) randomly...

Latest Links Processed

0/120